ArticleTranslational oncology2024

Non-small cell lung cancer cells with uncommon EGFR exon 19delins variants respond poorly to third-generation EGFR inhibitors.

Zhiqin Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.